Flora Tshinanu Musuamba

16PUBLICATIONS
34CO-AUTHORS
Infant and child healthPharmaceutical delivery technologiesSoftware quality, processes and metricsCancer therapy (excl. chemotherapy and radiation therapy)Air pollution modelling and control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 08, 2026
Why Pediatric CAR-T Therapies Still Lag Behind: Insights from Six Treatments Centrally Approved in Europe.

|Apr 04, 2026
Differences in Physiologically Based Pharmacokinetic Predictions between Software Platforms Can Be Clinically Relevant: Cases of Levornestrogel and Ethinylestradiol Concentrations with SIMCYP versus PK-Sim from a User Perspective.

Camille Massaux, Jean-Michel Dogné, Flora Tshinanu Musuamba

|Mar 24, 2026
Use of Modeling and Simulation to Inform the Development of Monoclonal Antibodies to Treat Moderate-to-Severe Asthma: A Retrospective Review of EMA Centralized Procedure From 2014 to 2024.

Hélène Haguet, Jean-Michel Dogné, Flora T Musuamba

|Mar 24, 2026
Modeling and Simulation in Development and Regulatory Approval of Chimeric Antigen Receptor T-Cell Therapies: An Analysis of European Medicines Agency Centralized Procedures From 2018 to 2024.

Lisa Hanquet, Jean-Michel Dogné, Flora T Musuamba

|Mar 02, 2026
Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices.

Happy Phanio Djokoto, Jean-Michel Dogné, Flora T Musuamba

|Feb 24, 2026
Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 2000 to December 2024.

Grace Shalom Govere, Jean-Michel Dogné, Flora Musuamba

Pageof 3

Frequent Collaborators

5 joint publications

Jean-Michel Dogné

2 joint publications

Pieter J Colin

2 joint publications

Francesco Pappalardo

1 joint publications

Grace Shalom Govere